ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival

被引：0
|
作者：
Ibrahim Said
Inge Ubink
Roos S. G. Ewalds
Johanna G. T. Arkesteijn
Henk M. W. Verheul
Johannes H. W. de Wilt
Helena M. Dekker
Andreas J. A. Bremers
Philip R. de Reuver
机构：
[1] Radboud Institute for Health Sciences,Radboudumc, Department of Surgery
[2] Radboud Institute for Health Sciences,Radboudumc, Department of Medical Oncology
[3] Radboud University Medical Centre,Radboudumc, Department of Medical Imaging
来源：
Annals of Surgical Oncology | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5263 / 5264
页数：1
相关论文
共 50 条
  • [1] ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival
    Said, Ibrahim
    Ubink, Inge
    Ewalds, Roos S. G.
    Arkesteijn, Johanna G. T.
    Verheul, Henk M. W.
    de Wilt, Johannes H. W.
    Dekker, Helena M.
    Bremers, Andreas J. A.
    de Reuver, Philip R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (8) : 5263 - 5264
  • [2] In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival
    Ibrahim Said
    Inge Ubink
    Roos S. G. Ewalds
    Johanna G. T. Arkesteijn
    Henk M. W. Verheul
    Johannes H. W. de Wilt
    Helena M. Dekker
    Andreas J. A. Bremers
    Philip R. de Reuver
    Annals of Surgical Oncology, 2022, 29 : 5256 - 5262
  • [3] In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival
    Said, Ibrahim
    Ubink, Inge
    Ewalds, Roos S. G.
    Arkesteijn, Johanna G. T.
    Verheul, Henk M. W.
    de Wilt, Johannes H. W.
    Dekker, Helena M.
    Bremers, Andreas J. A.
    de Reuver, Philip R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 5256 - 5262
  • [4] ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
    Dietz, Michelle V.
    Ziekman, Merijn J.
    van Kooten, Job P.
    Brandt-Kerkhof, Alexandra R. M.
    van Meerten, Esther
    Verhoef, Cornelis
    Madsen, Eva V. E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2057 - 2057
  • [5] ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
    Michelle V. Dietz
    Merijn J. Ziekman
    Job P. van Kooten
    Alexandra R. M. Brandt-Kerkhof
    Esther van Meerten
    Cornelis Verhoef
    Eva V. E. Madsen
    Annals of Surgical Oncology, 2023, 30 : 2057 - 2057
  • [6] Novel Prognostic Scoring System for Prediction of Survival Outcomes in Patients undergoing CRS-HIPEC for Colorectal Peritoneal Metastasis
    Chin, K.
    Tan, G.
    Chia, C.
    Ong, J. C.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S114 - S115
  • [7] ASO Visual Abstract: Limited Prognostic Value of KRAS for Patients Undergoing Hepatectomy for Colorectal Liver Metastases
    Takeda, Yoshinori
    Mise, Yoshihiro
    Takahashi, Yu
    Ito, Hiromichi
    Inoue, Yosuke
    Yoshioka, Ryuji
    Ono, Yoshihiro
    Saiura, Akio
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (04) : 2392 - 2392
  • [8] ASO Visual Abstract: Limited Prognostic Value of KRAS for Patients Undergoing Hepatectomy for Colorectal Liver Metastases
    Yoshinori Takeda
    Yoshihiro Mise
    Yu Takahashi
    Hiromichi Ito
    Yosuke Inoue
    Ryuji Yoshioka
    Yoshihiro Ono
    Akio Saiura
    Annals of Surgical Oncology, 2022, 29 : 2392 - 2392
  • [9] Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
    Graf, Wilhelm
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Botling, Johan
    Terman, Alexei
    Birgisson, Helgi
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (01) : 293 - 300
  • [10] Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
    Wilhelm Graf
    Peter H. Cashin
    Lana Ghanipour
    Malin Enblad
    Johan Botling
    Alexei Terman
    Helgi Birgisson
    Annals of Surgical Oncology, 2020, 27 : 293 - 300
12345